The wacky world of HIV has given up searching for an HIV vaccine.  No
surprise, really.

<http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=51109>:

----- Begin Quote -----

Trials of NIH's Vaccine Research Center's HIV vaccine candidate will
be scaled down after the recent failure of a Merck HIV vaccine
candidate, Bloomberg reports (Lauerman, Bloomberg, 3/24). Merck in
September 2007 announced it had halted a large-scale clinical trial of
its experimental HIV vaccine after the drug failed to prevent HIV
infection in participants or prove effective in delaying the
progression of the virus to AIDS. The vaccine candidate also might
have put some trial participants at an increased risk of HIV (Kaiser
Daily HIV/AIDS Report, 3/21).

The VRC candidate, called PAVE-100, is similar to the Merck vaccine in
that both stimulate CD4+ T cells against HIV and both contain the cold
virus adenovirus-5. Researchers in the Merck trial found that men who
received that vaccine were at an increased risk of contracting HIV...

[...]

VRC initially planned to enroll 8,500 people in the U.S. and Africa in
the trial but now plans to enroll only 2,000. In addition, IAVI on
Monday announced plans to pull out of the VRC trial.

----- End Quote -----

And it gets better...

----- Begin Quote -----

According to Bloomberg, some researchers have said that the failure of
the Merck vaccine has set back HIV vaccine research for years, and
many researchers are questioning new trials. The AIDS Healthcare
Foundation recently called for all HIV vaccine research to be stopped.
NIAID on Tuesday is expected to hold a meeting with HIV/AIDS
researchers to discuss its $497 million HIV vaccine research program.
Bruce Walker, a researcher at Harvard Medical School, said the NIAID
meeting will aim "to stop and take stock" of HIV vaccine development
following the "unanticipated result" of the Merck trials (Bloomberg,
3/24).

----- End Quote -----

LOL, LOL, LOL.  Anyone still believe the HIV lie?